Edasalonexent, an NF-kB Inhibitor, Slows Longer-Term Disease Progression on Multiple Functional and MRI Assessments Compared to Control Period in 4 to 7-Year Old Patients with Duchenne Muscular Dystrophy (S51.006)

20192 citationsJournal Article

Authors

Edasalonexent is an orally administered small molecule inhibiting NF-kB under development for Duchenne muscular dystrophy (DMD).

Good health and well-being

Published in: Neurology

Volume 92, Issue 15_supplement

Field-Weighted Citation Impact: 0.17